- Jack Coleman, Jr. M.D. from the Lung Institute presented the developments made in Stem Cell Therapy at the international conference held in the Italian city of Padua. The conference was about the current use of stem cells and their future applications. Dr. Coleman discussed on lunginstitute.com how traditional approach in medicine science needs to be changed to get benefits of Stem Cell Therapy. He argued that the regular ways of introducing an instrument or medicine in the US are very slow, cumbersome, expensive, and unsuitable.
- Coleman examined how the conventional funding and functioning of research is conducted. He discussed in detail the process of taking treatment from laboratory to hospital and clinic. He also explained how a process is regulated, and how much cost and time are spent on implementing the new treatments. According to him, the entire process is a hindrance to the progress because it is outdated. He compared the healthcare system of United States with other countries. He reviewed the solutions introduced by other countries for patient care and the difference in results.
In an article on PR Web, many speakers, researchers, and stakeholders from different countries attended the conferences where they discussed the function of stem cells in the body and their ethical implications. Dr. Shinya Yamanaka joined the conference from Japan through video linking. He won Nobel Prize in the field of genetics in 2012. Dr. Coleman emphasized on the fact that the practice of medicine in the US is changing because of stem cell technologies. He concluded that it is the responsibility of medical practitioners to provide the safest and best treatment to people for relieving their sufferings and pain.
The Lung Institute strives to improve the life of people who suffer from lung diseases. It is the leading institute in this field with five branches in the US. Over three thousand patients were treated at the Lung Institute with eighty-five percent of them feeling better. According to the Lung Institute website, they developed the protocol of Stem Cell Therapy for treating lung diseases instead of only dealing with the symptoms. The new approach is to derive stem cells from the patient’s body to harness the natural healing of his body.